L. Puig

Research interests

Publications

• Prevalence of most common skin diseases in Europe: a population‐based study

  Journal of the European Academy of Dermatology and Venereology · 2022 · 10.1111/jdv.18050

• Prevalence of most common skin diseases in Europe: a population‐based study

  Journal of the European Academy of Dermatology and Venereology · 2022 · 10.1111/jdv.18050

• Comparison of Biologics and Oral Treatments for Plaque Psoriasis

  JAMA Dermatology · 2020 · 10.1001/jamadermatol.2019.4029

• Comparison of Biologics and Oral Treatments for Plaque Psoriasis

  JAMA Dermatology · 2020 · 10.1001/jamadermatol.2019.4029

• Recategorization of psoriasis severity: Delphi consensus from the International Psoriasis Council

  Journal of the American Academy of Dermatology · 2019 · https://doi.org/10.1016/j.jaad.2019.08.026

• Critical role of interleukin (IL)-17 in inflammatory and immune disorders: An updated review of the evidence focusing in controversies

  Autoimmunity Reviews · 2019 · https://doi.org/10.1016/j.autrev.2019.102429

• Clinical and genetic differences between pustular psoriasis subtypes

  Journal of Allergy and Clinical Immunology · 2018 · 10.1016/j.jaci.2018.06.038

• Epidemiology of atopic dermatitis in adults: Results from an international survey

  Allergy · 2018 · https://doi.org/10.1111/all.13401

• Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials

  The Lancet · 2018 · https://doi.org/10.1016/s0140-6736(18)31713-6

• The Pathogenesis of Extraintestinal Manifestations: Implications for IBD Research, Diagnosis, and Therapy

  Journal of Crohn s and Colitis · 2018 · 10.1093/ecco-jcc/jjy191

• Clinical and genetic differences between pustular psoriasis subtypes

  Journal of Allergy and Clinical Immunology · 2018 · 10.1016/j.jaci.2018.06.038

• The Pathogenesis of Extraintestinal Manifestations: Implications for IBD Research, Diagnosis, and Therapy

  Journal of Crohn s and Colitis · 2018 · 10.1093/ecco-jcc/jjy191

• European consensus statement on phenotypes of pustular psoriasis

  Journal of the European Academy of Dermatology and Venereology · 2017 · https://doi.org/10.1111/jdv.14386

• The role of IL ‐23 and the IL ‐23/ T H 17 immune axis in the pathogenesis and treatment of psoriasis

  Journal of the European Academy of Dermatology and Venereology · 2017 · https://doi.org/10.1111/jdv.14433

• Development and validation of the International Hidradenitis Suppurativa Severity Score System ( IHS 4), a novel dynamic scoring system to assess HS severity

  British Journal of Dermatology · 2017 · https://doi.org/10.1111/bjd.15748

• Efficacy and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: results of the randomized, double‐blind, phase III NAVIGATE trial

  British Journal of Dermatology · 2017 · https://doi.org/10.1111/bjd.15750

• Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis

  New England Journal of Medicine · 2015 · https://doi.org/10.1056/nejmoa1503824

• Physician perspectives in the management of psoriasis and psoriatic arthritis: results from the population‐based Multinational Assessment of Psoriasis and Psoriatic Arthritis survey

  Journal of the European Academy of Dermatology and Venereology · 2015 · https://doi.org/10.1111/jdv.13150

• Ustekinumab, an anti-IL-12/23 p40 monoclonal antibody, inhibits radiographic progression in patients with active psoriatic arthritis: results of an integrated analysis of radiographic data from the phase 3, multicentre, randomised, double-blind, placebo-controlled PSUMMIT-1 and PSUMMIT-2 trials

  Annals of the Rheumatic Diseases · 2014 · 10.1136/annrheumdis-2013-204741

• Efficacy and safety of the anti-IL-12/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological anti-tumour necrosis factor therapy: 6-month and 1-year results of the phase 3, multicentre, double-blind, placebo-controlled, randomised PSUMMIT 2 trial

  Annals of the Rheumatic Diseases · 2014 · https://doi.org/10.1136/annrheumdis-2013-204655

• Actinic keratosis with atypical basal cells ( AK I) is the most common lesion associated with invasive squamous cell carcinoma of the skin

  Journal of the European Academy of Dermatology and Venereology · 2014 · 10.1111/jdv.12848

• Ustekinumab, an anti-IL-12/23 p40 monoclonal antibody, inhibits radiographic progression in patients with active psoriatic arthritis: results of an integrated analysis of radiographic data from the phase 3, multicentre, randomised, double-blind, placebo-controlled PSUMMIT-1 and PSUMMIT-2 trials

  Annals of the Rheumatic Diseases · 2014 · 10.1136/annrheumdis-2013-204741

• Patient perspectives in the management of psoriasis: Results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis Survey

  Journal of the American Academy of Dermatology · 2014 · https://doi.org/10.1016/j.jaad.2013.12.018

• Actinic keratosis with atypical basal cells ( AK I) is the most common lesion associated with invasive squamous cell carcinoma of the skin

  Journal of the European Academy of Dermatology and Venereology · 2014 · 10.1111/jdv.12848

• Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials

  New England Journal of Medicine · 2014 · https://doi.org/10.1056/nejmoa1314258

• Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial

  The Lancet · 2013 · https://doi.org/10.1016/s0140-6736(13)60594-2

• Obesity and psoriasis: body weight and body mass index influence the response to biological treatment

  Journal of the European Academy of Dermatology and Venereology · 2011 · 10.1111/j.1468-3083.2011.04065.x

• Obesity and psoriasis: body weight and body mass index influence the response to biological treatment

  Journal of the European Academy of Dermatology and Venereology · 2011 · 10.1111/j.1468-3083.2011.04065.x

• Psoriasis and Systemic Inflammatory Diseases: Potential Mechanistic Links between Skin Disease and Co-Morbid Conditions

  Journal of Investigative Dermatology · 2010 · https://doi.org/10.1038/jid.2010.103

• Seroprevalence of Trypanosoma cruzi infection in at‐risk blood donors in Catalonia (Spain)

  Transfusion · 2008 · https://doi.org/10.1111/j.1537-2995.2008.01789.x

• Development of a real-time PCR assay for Trypanosoma cruzi detection in blood samples

  Acta Tropica · 2007 · https://doi.org/10.1016/j.actatropica.2007.05.019

Current projects

No projects listed.